Genome Editing has a broad spectrum of potential applications. It has already secured a fixed place in basic research and many applications are on the starting blocks. What are the arguments for and against the implementation of Genome Editing in plant and animal breeding and in humans? This is a question, that rises from the ethical point of view.

  • Working Group Genome Editing
    Many questions concerning methods in gene technology have been discussed extensively in the past. Is genome editing just another molecular method like those in gene technology, from the ethical point of view? Or do there arise new additional ethical questions? What would they be? A working group of the ethics platform deals with issues related to genome editing over a considerable period of time.
  • Lectures Potenzial und Risiken von Genome Editing bei Nutzpflanzen (R. Wilhelm, Julius Kühn-Institut, Quedlinburg, D, Angelika Hilbeck, Institut für Integrative Biologie, ETH Zürich, CH)
  • Lecture Organic farming and Genome Editing (U. Niggli, Forschungsinstitut für Biologischen Landbau, Frick, Switzerland)
  • Gene Drive
    The conference „Fighting Malaria with CRISPR/Cas9: Ethical Implications“ has been organized by the UNESCO Chair on Bioethics, MUW/Josephinum, in Cooperation with the Ethics Platform BOKU and CERMEL in September 2016. There, W. Liebert from the Institute of Safety and Risk Sciences, BOKU, Chair of the Ethics Platform BOKU, gave the lecture "Comparing CRISPR/Cas9 with other Techniques: Aspects of Prospective Technology Assessment".